Additionally, a worse clinical course was observed among patients whose tumors had mutations in NOTCH genes and PIK3CA. This study is the first to identify the most common genetic alterations among HL women with TNBC. This evidence concerns the gene PIK3CA and Hodgkins lymphoma.